DFX Intelligence
Private Equity Intelligence
Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.
The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.
Firms / A••••• A•••• M••••••••• S•••
A••••• A•••• M••••••••• S•••
Classification
- Class
- Buyout firmconfirmed, confidence 85%
- Basis
- R6: 33 of 33 distinct vehicles are sworn Private Equity Funds; 31 reported gross assets on a filing in 2022 or later
- Size band
- Upper middle marketdefined by: proxy: $22.05bn Private Equity Fund GAV on the Form ADV filed 2024-03-26
Classification history (1)
- Sep 13, 2026Buyout firm (confirmed, 85%, cls-pe-1)R6: 33 of 33 distinct vehicles are sworn Private Equity Funds; 31 reported gross assets on a filing in 2022 or later
Regulatory footprint (Form ADV)
- Adviser type
- exempt reporting adviser
- Form ADV filings
- Mar 24, 2017 to Mar 26, 2024
- RAUM
- unknownregulatory assets under management of the adviser; not dry powder, not a fund size
- PE funds, latest filing
- 31
- PE fund GAV, latest filing
- $22Breported gross assets (Form ADV), not fund size
- All private fund GAV
- $22Bevery private fund type, latest filing
- 2024 PE fund GAV
- $22Bsum over funds typed Private Equity Fund with a 2024 or later as-of date
- PE share of funds, lifetime
- 100%
- Fund type mix
- filed 2024-03-26, latest gav Private Equity Fund $22B, latest counts Private Equity Fund 31, lifetime distinct Private Equity Fund 33
- Employees
- unknown
- Headquarters
- Luxembourg, Luxembourg
- Office address
- 15, RUE EDWARD STEICHEN, Luxembourg, L-2540
- Business phone
- 00352 26 09 21 1
Stated criteria beside observed behaviour
19 observed deals
Stated by the firm
- Sectors
- healthcare, financial services, consumer
- Geography
- not stated or not yet read
- Revenue
- not stated or not yet read
- EBITDA
- not stated or not yet read
- Enterprise value
- not stated or not yet read
- Equity check
- not stated or not yet read
- Control
- not stated or not yet read
- Thesis
- Our investment process ensures we fully understand the strength of the strategic fundamentals of the companies we invest in, and chart the right path for future value creation.
Observed from deals on record
- roles
- unknown 16, platform 5
- period
- to 2026-08-12, from 2022-01-01, undated holdings 6, dated observations 18
- window
- last 2026-08-12, first 2026-03-30
- control
- control 5, unknown 16
- companies
- 19
- geography
- investments
- 21
- seller kinds
- unknown 4
- transactions
- 5
- cadence by year
- 2026 platforms 3
- platform add on
- add ons 0, platforms 5, add ons per platform 0
- sector known for
- 7
- disclosed value usd
- n 0
- sector distribution
- count 2, share 0.105, value software, examples Sofico, Acturis, count 2, share 0.105, value life sciences, examples hg medical, Solabia, count 1, share 0.053, value business services, examples Attikon, count 1, share 0.053, value agriculture, examples Fastmarkets, count 1, share 0.053, value specialty distribution, examples Steliau
- holding period years
- n 0
- repeat counterparties
- role buy side adviser, shared 2, entity id 132d77df-99af-4701-95a4-0947507390db, role buy side adviser, shared 2, entity id 34593a54-b97d-4238-bd54-343b6916fea0, role buy side adviser, shared 2, entity id df6c4684-25ea-49ef-b7c2-561c688425b7, role buy side adviser, shared 2, entity id 69bccd9c-a076-4d00-80a1-676d9a5914ac, role buy side adviser, shared 2, entity id 3d601903-d5f1-4da8-a757-72e9c1794289, role buy side adviser, shared 2, entity id 8c948cab-733a-4ae2-a08a-188550fa2c7d, role sell side adviser, shared 2, entity id 852b4697-10ec-4537-ac08-40f85f4a61b6, role sell side adviser, shared 2, entity id abda39d3-d175-4643-b677-4f391008c057, role sell side adviser, shared 2, entity id 03c7c431-40a2-42b0-b86d-10a4f803d55c, role sell side adviser, shared 2, entity id 69bccd9c-a076-4d00-80a1-676d9a5914ac, role sell side adviser, shared 2, entity id 13609de8-966c-4670-b145-303a8fb8504d, role sell side adviser, shared 2, entity id 592acdc8-a12d-4288-bee1-67db428bb02e
- subsector distribution
- count 2, share 0.105, value software, examples Sofico, Acturis, count 1, share 0.053, value insurance agencies brokerage, examples Attikon, count 1, share 0.053, value agriculture, examples Fastmarkets, count 1, share 0.053, value misc durable wholesale, examples Steliau, count 1, share 0.053, value medical devices, examples hg medical, count 1, share 0.053, value life sciences, examples Solabia
19 companies on the graph (5 transactions); most in software (2); 5 platforms and 0 add-ons; observed 2022 to 2026
Funds
33 on record
| Fund | Vehicle | Vintage | Reported gross assets (Form ADV), not fund size | GAV by year | Form D sold | Lifecycle |
|---|---|---|---|---|---|---|
| A••••• N••••• F••• ADV: Private Equity Fund | buyout or unlabelled | 2024 first reported on Form ADV | $0 as of Mar 26, 2024 | no Form D | Unknown | |
| A••••• G• E••••• S•••••••• ADV: Private Equity Fund | Fund of funds | 2024 first reported on Form ADV | $0 as of Mar 26, 2024 | no Form D | Unknown | |
| A••••• V••• C•••••••• C••••• ADV: Private Equity Fund | co i•••••ment | 2023 first reported on Form ADV | $1.4B as of Mar 26, 2024 | no Form D | Early deployment | |
| A••••• V••• C•••••••• L•••••• ADV: Private Equity Fund | co i•••••ment | 2023 first reported on Form ADV | $578M as of Mar 26, 2024 | no Form D | Early deployment | |
| A••••• I••••• 2• S••••••••• ADV: Private Equity Fund | buyout or unlabelled | 2023 first reported on Form ADV | $511M as of Mar 26, 2024 | no Form D | Early deployment | |
| A••••• V••• C•••••••• C••••• F• ADV: Private Equity Fund | co i•••••ment | 2023 first reported on Form ADV | $328M as of Mar 26, 2024 | no Form D | Unknown | |
| A••••• V••• C•••••••• O••• H••••• ADV: Private Equity Fund | co i•••••ment | 2023 first reported on Form ADV | $223M as of Mar 26, 2024 | no Form D | Early deployment | |
| A••• V••• ADV: Private Equity Fund | buyout or unlabelled | 2023 first reported on Form ADV | $145M as of Mar 26, 2024 | no Form D | Early deployment | |
| A••• V••• ADV: Private Equity Fund | buyout or unlabelled | 2023 first reported on Form ADV | $80.6M as of Mar 26, 2024 | no Form D | Early deployment | |
| A••••• V•• C•••••••• E••••••• ADV: Private Equity Fund | co i•••••ment | 2023 first reported on Form ADV | $72.6M as of Mar 26, 2024 | no Form D | Early deployment | |
| A••••• C•••••••• A••••• ADV: Private Equity Fund | co i•••••ment | 2023 first reported on Form ADV | $64.5M as of Mar 26, 2024 | no Form D | Early deployment | |
| A••••• C•••••••• A•••• ADV: Private Equity Fund | co i•••••ment | 2023 first reported on Form ADV | $58.5M as of Mar 26, 2024 | no Form D | Unknown | |
| A••••• I••••• 3• S••••••••• ADV: Private Equity Fund | buyout or unlabelled | 2023 first reported on Form ADV | $29.1M as of Mar 26, 2024 | no Form D | Early deployment | |
| A••••• V••• ADV: Private Equity Fund | buyout or unlabelled | 2022 first reported on Form ADV | $2.3B as of Mar 26, 2024 | no Form D | Early deployment | |
| A••••• I•••• F••• ADV: Private Equity Fund | buyout or unlabelled | 2022 first reported on Form ADV | $2.2B as of Mar 26, 2024 | no Form D | Early deployment | |
| A••••• V•• C•••••••• S••••• S•• ADV: Private Equity Fund | co i•••••ment | 2022 first reported on Form ADV | $1.8B as of Mar 26, 2024 | no Form D | Early deployment | |
| A••••• V••• ••••••• ADV: Private Equity Fund | f••••• | 2022 first reported on Form ADV | $653M as of Mar 26, 2024 | no Form D | Early deployment | |
| A••••• I••••• S••••••••• ADV: Private Equity Fund | buyout or unlabelled | 2022 first reported on Form ADV | $615M as of Mar 26, 2024 | no Form D | Early deployment | |
| A••••• V•• C•••••••• D•••••• S•• ADV: Private Equity Fund | co i•••••ment | 2022 first reported on Form ADV | $132M as of Mar 26, 2024 | no Form D | Unknown | |
| A••••• M•••••• C•••••••• O••• 2• S•• ADV: Private Equity Fund | co i•••••ment | 2022 first reported on Form ADV | $124M as of Mar 26, 2024 | no Form D | Early deployment | |
| A••••• V•• C•••••••• F•••••• S•• ADV: Private Equity Fund | co i•••••ment | 2022 first reported on Form ADV | $113M as of Mar 26, 2024 | no Form D | Early deployment | |
| A••••• V•• C•••••••• C•••• S•• ADV: Private Equity Fund | co i•••••ment | 2022 first reported on Form ADV | $92.3M as of Mar 26, 2024 | no Form D | Unknown | |
| A••••• V•• C•••••••• E•• S•• ADV: Private Equity Fund | co i•••••ment | 2021 first reported on Form ADV | $804M as of Mar 26, 2024 | no Form D | Active deployment | |
| A••••• M•••••• ADV: Private Equity Fund | Buyout fund | 2021 first reported on Form ADV | $581M as of Mar 26, 2024 | no Form D | Active deployment | |
| A••••• V•• C•••••••• L•• S•• ADV: Private Equity Fund | co i•••••ment | 2021 first reported on Form ADV | $516M as of Mar 26, 2024 | no Form D | Unknown | |
| A••••• V•• C•••••••• A••••• ADV: Private Equity Fund | co i•••••ment | 2020 first reported on Form ADV | $321M as of Mar 26, 2024 | no Form D | Active deployment | |
| A••••• V• C•••••••• N••••• ADV: Private Equity Fund | co i•••••ment | 2020 first reported on Form ADV | $169M as of Mar 26, 2024 | no Form D | Active deployment | |
| A••••• V••• S•• ADV: Private Equity Fund | buyout or unlabelled | 2019 first reported on Form ADV | $6.7B as of Mar 26, 2024 | no Form D | Mature | |
| A••••• V• C•••••••• I•• R••••• ADV: Private Equity Fund | co i•••••ment | 2019 first reported on Form ADV | $8.8M as of Mar 26, 2024 | no Form D | Harvest | |
| A••••• V• C•••••••• A•••• S••• ADV: Private Equity Fund | co i•••••ment | 2018 first reported on Form ADV | $35.7M as of Mar 26, 2024 | no Form D | Unknown | |
| A••••• V•• S•• ADV: Private Equity Fund | buyout or unlabelled | unknown | $1.4B as of Mar 26, 2024 | no Form D | Mature | |
| A••••• C•••••••• A••••••• ADV: Private Equity Fund | co i•••••ment | unknown | $77,034 as of Apr 21, 2023 | no Form D | Wound down | |
| A••••• V• C•••••••• P•••••• ADV: Private Equity Fund | co i•••••ment | unknown | $68,838 as of Apr 21, 2023 | no Form D | Wound down |
Team
16 current, 5 former
Managing partner (1)
- J••••• C••••••••• · Co-Managing Partner and Head of H•••••care · start date unknown Press release wires (PR Newswire, GlobeNewswire, B••••••• Wire public pages and RSS)
Partner (4)
- M•••• A•••••••• · Managing Director, Technology Flagship · start date unknown I•••••ment organization websites (team, portfolio, strategy, criteria, news)
- O•••••• L••••• · Partner · start date unknown Press release wires (PR Newswire, GlobeNewswire, B••••••• Wire public pages and RSS)
- P••• A••••••••• · Managing Director, H•••••care Flagship · start date unknown I•••••ment organization websites (team, portfolio, strategy, criteria, news)
- P••• A••••••••• · Managing Director · start date unknown Press release wires (PR Newswire, GlobeNewswire, B••••••• Wire public pages and RSS)
Principal (4)
- B••••••• C••••••••• · Director B••••••• Services I•••••ments · start date unknown Press release wires (PR Newswire, GlobeNewswire, B••••••• Wire public pages and RSS)
- B••••••• C••••••••• · Director B••••••• Services I•••••ments · start date unknown Press release wires (PR Newswire, GlobeNewswire, B••••••• Wire public pages and RSS)
- F•••••••• A•••• S•••••• · Director, Financial Information & Valuation · start date unknown I•••••ment organization websites (team, portfolio, strategy, criteria, news)
- R••• A•••••••• · Director, Fund Administration · start date unknown I•••••ment organization websites (team, portfolio, strategy, criteria, news)
Associate (2)
- E•• A•••• · Associate, Financial Information & Valuation · start date unknown I•••••ment organization websites (team, portfolio, strategy, criteria, news)
- F••••••• A•••••• · Associate · start date unknown I•••••ment organization websites (team, portfolio, strategy, criteria, news)
Platform (3)
- J•••• B••• O•••• · Managing Director, Head of Group Finance · start date unknown I•••••ment organization websites (team, portfolio, strategy, criteria, news)
- L••••• A•••••• · Receptionist & Facilities Assistant, Luxembourg · start date unknown I•••••ment organization websites (team, portfolio, strategy, criteria, news)
- N••• B••••••••• · Executive Assistant · start date unknown I•••••ment organization websites (team, portfolio, strategy, criteria, news)
i•••••or relations (2)
- M•••• A•••• · Senior Associate, I•••••or Relations · start date unknown I•••••ment organization websites (team, portfolio, strategy, criteria, news)
- P••• A•••• · Senior Associate, I•••••or Relations · start date unknown I•••••ment organization websites (team, portfolio, strategy, criteria, news)
5 former (kept with end dates)
- J••• L••••••• · Shareholder · Oct 1, 2012 to Mar 28, 2019 Inference
- T•••••• T••••• · Shareholder · Oct 1, 2012 to Mar 28, 2019 Inference
- X••••• M••••• · Shareholder · Jan 1, 2014 to Mar 28, 2019 Inference
- G•••••••• d• M••••••• · Conducting Officer · Sep 1, 2015 to Mar 28, 2019 Inference
- O•••••• G•••• · Conducting Officer · Oct 1, 2016 to Mar 28, 2019 Inference
Portfolio
21 relationships, 5 platforms, 0 add-ons
Transactions
5 on record
| Date | Type | Target | This firm’s role | Source |
|---|---|---|---|---|
| Aug 12, 2026 | Platform acquisition | M••••••••• b••••••• | Sponsor (confirmed) | astorg.com |
| Apr 27, 2026 | Platform acquisition | G••••• M••••••••• B••••••• | Sponsor (confirmed) | astorg.com |
| Mar 30, 2026 | Platform acquisition | B•••••• | Sponsor (confirmed) | astorg.com |
| date unknown | Platform acquisition | I•••• | Sponsor (confirmed) | alphape.com |
| date unknown | Platform acquisition | I•••• | Sponsor (confirmed) | alphape.com |
Placement agents, lenders, advisers and co-investors
23 relationships
Placement agents (2)
- P••• H••• G•••• L•• 5 shared · very strong · last Jan 1, 2022
- M••••••• G••••• I••• 1 shared · one time · last Jan 1, 2024
Financial advisers (21)
- E•• 3 shared · strong · last Mar 30, 2026
- B•• 2 shared · recurring
- L••••• • W•••••• L•• 2 shared · recurring
- A•••• • O•••• L•• 2 shared · recurring
- R••••• B••••• 2 shared · recurring
- A•••••• 2 shared · recurring
- E•• L•• 2 shared · recurring
- A•• C•••••• 2 shared · recurring
- M•••• L•• 2 shared · recurring
- K••• L•• 2 shared · recurring
- F••• A••••• 2 shared · recurring
- D••••••• 2 shared · recurring
- S••• 1 shared · one time · last Mar 30, 2026
- H•••• L•••••• 1 shared · one time · last Mar 30, 2026
- W•• 1 shared · one time · last Mar 30, 2026
- L••••• 1 shared · one time · last Apr 27, 2026
- B••• • C•••••• 1 shared · one time · last Mar 30, 2026
- K••••••• • E•••• L•• 1 shared · one time · last Mar 30, 2026
- S•••••• P••••••• 1 shared · one time · last Mar 30, 2026
- M••••• • C•••••• L•• 1 shared · one time · last Apr 27, 2026
- E••••••• 1 shared · one time · last Apr 27, 2026
LP commitments
0 disclosed
No LP commitment collected yet. An LP edge needs a public disclosure with a quote, such as a pension plan’s report or an announcement naming the LP.
Events
12 most recent
- Sep 3, 2026A••••• completes acquisition of M••••••••• b••••••• from Thermo Fisher Scientific, establishing an independent global diagnostics specialist H•••••care 12 August 2026
- Aug 12, 2026A••••• completes acquisition of M••••••••• b••••••• from Thermo Fisher Scientific, establishing an independent global diagnostics specialist H•••••care 12 August 2026
- Jun 4, 2026A•••••-backed C•••••Pharma acquires AmbioPharm, strengthening its position as a leading global peptide development and manufacturing platform H•••••care 04 June 2026
- Jun 1, 2026A•••••-backed S•••••• to acquire Acal BFI, strengthening its position as the leading European platform in value-added electronic s•••••••• B••••••• Services 01 June 2026
- Apr 27, 2026A••••• to Acquire G••••• M••••••••• B••••••• from Thermo Fisher Scientific H•••••care 27 April 2026
- Apr 27, 2026A••••• to Acquire G••••• M••••••••• B••••••• from Thermo Fisher Scientific H•••••care 27 April 2026
- Mar 30, 2026A••••• Mid Cap to acquire B••••••, a leading multi-specialist B2B technical services platform B••••••• Services 30 March 2026Platform i•••••mentFactB••••••Press release wires (PR Newswire, GlobeNewswire, B••••••• Wire public pages and RSS)
- Mar 30, 2026A••••• A•••• M••••••••• S•••: Private Equity Funds on Form ADV 31 (2024 extract) -> 40 (roster 2026-09-01)
- Mar 30, 2026A••••• Mid Cap to acquire B••••••, a leading multi-specialist B2B technical services platform B••••••• Services 30 March 2026
- Mar 5, 2026A••••• Portfolio Company S•••••• accelerates expansion plan with three strategic acquisitions Industrials 05 March 2026
- Sep 16, 2025A•••••-backed R•••••• acquires CatMan Solution to create a global data powerhouse Tech 16 September 2025
- Mar 24, 2017A••••• A•••• M••••••••• S••• first filed Form ADV in the extract (ERA)
Across the graphs
A••••• A•••• M••••••••• S••• is the same institution as 1 record in Venture Capital.
Venture Capital1
Which record it is in each graph, what it is called there, and what the two were joined on. The Data Factory holds all nine graphs and the identity layer between them.
Checking your plan…